Boston Common Asset Management LLC Acquires 36,101 Shares of Roche Holding AG $RHHBY

Key Points

• Boston Common Asset Management LLC increased its stake in Roche Holding AG by 11.1%, acquiring an additional 36,101 shares during the second quarter, bringing its total holdings to 361,833 shares valued at approximately $14.7 million.
• Several other institutional investors also boosted their stakes in Roche, with Bard Financial Services increasing its ownership by 25.3% and Moloney Securities Asset Management raising its stake by 53.8%.
• Roche's stock was upgraded by HSBC from "hold" to "strong buy," with analysts setting a consensus target price of $50.00, indicating positive market sentiment around the company's future performance.

Boston Common Asset Management LLC boosted its holdings in Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 11.1% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 361,833 shares of the company's stock after acquiring an additional 36,101 shares during the quarter. Boston Common Asset Management LLC's holdings in Roche were worth $14,682,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in RHHBY. Bard Financial Services Inc. increased its stake in Roche by 25.3% in the 1st quarter. Bard Financial Services Inc. now owns 138,900 shares of the company's stock worth $5,716,000 after acquiring an additional 28,050 shares during the last quarter. Corient IA LLC bought a new position in Roche in the 1st quarter worth about $616,000. Moloney Securities Asset Management LLC increased its stake in Roche by 53.8% in the 1st quarter. Moloney Securities Asset Management LLC now owns 40,732 shares of the company's stock worth $1,672,000 after acquiring an additional 14,245 shares during the last quarter. FCA Corp TX bought a new position in Roche in the 1st quarter worth about $494,000. Finally, Everett Harris & Co. CA bought a new position in Roche in the 1st quarter worth about $445,000.

Roche Trading Up 1.3%

Shares of Roche stock opened at $45.30 on Friday. The business's 50-day moving average price is $40.76 and its 200-day moving average price is $40.25. Roche Holding AG has a 12 month low of $34.10 and a 12 month high of $45.46.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. Hsbc Global Res upgraded Roche from a "hold" rating to a "strong-buy" rating in a research note on Thursday. HSBC upgraded Roche from a "hold" rating to a "buy" rating and set a $50.00 price objective on the stock in a research report on Thursday. Three research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and one has issued a Hold rating to the company's stock. According to MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $50.00.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.